{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/pulmonary-embolism/","result":{"data":{"firstChapter":{"id":"7d60ce89-0a3c-5336-a5d4-755eb5bfb2cd","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 2dd0a685-85b9-4fb7-b18d-f903930f7ab5 --><h1>Pulmonary embolism: Summary</h1><!-- end field 2dd0a685-85b9-4fb7-b18d-f903930f7ab5 -->","htmlStringContent":"<!-- begin item 3f213c5e-7075-4e43-9bbd-437eb031e9f1 --><!-- begin field 57cc3edf-55dc-4e36-8750-81d5072a7bb5 --><ul><li>Pulmonary embolism (PE) is a condition in which one or more emboli, usually arising from a blood clot formed in the veins, are lodged in and obstruct the pulmonary arterial system, causing severe respiratory dysfunction.</li><li>The most common source of pulmonary emboli is deep vein thrombosis (DVT) in the lower limbs.</li><li>Major risk factors for PE include:<ul><li>DVT.</li><li>Previous DVT or PE.</li><li>Active cancer.</li><li>Recent surgery.</li><li>Lower limb trauma.</li><li>Significant immobility, for example, due to hospitalization.</li><li>Pregnancy and, in particular, for 6 weeks' postpartum.</li></ul></li><li>Other risk factors include use of combined oral contraception or hormone replacement therapy, known thrombophilias, long-distance travel, obesity, and increasing age (older than 60 years of age).</li><li>If PE is left untreated, the prognosis is poor and risk of death is high. Following treatment, some people develop complications, such as chronic thromboembolic pulmonary hypertension, which is associated with considerable morbidity and mortality.</li><li>PE should be suspected in people with one or more of the following (especially if there are risk factors for PE):<ul><li>Dyspnoea, chest pain, cough, haemoptysis, features of DVT (including leg pain and swelling [usually unilateral], lower abdominal pain, redness, increased temperature, and venous distension), dizziness, and syncope.</li><li>Tachypnoea or tachycardia, hypoxia, pyrexia, elevated jugular venous pressure, gallop rhythm, pleural rub, hypotension, and shock. </li></ul></li><li>If PE is suspected, a history, physical examination, and investigations should be carried out to exclude other causes of symptoms, such as acute coronary syndrome and pneumonia.</li><li>Immediate admission to hospital should be arranged if the person:<ul><li>Has signs of haemodynamic instability (including pallor, tachycardia, hypotension, shock, and collapse). </li><li>Is pregnant or has given birth within the past 6 weeks.</li></ul></li><li>For all other people, the two-level PE Wells score should be used to estimate the clinical probability of PE.</li><li>For people with a Wells score of more than 4 points (PE likely): <ul><li>Hospital admission for an immediate computed tomography pulmonary angiogram (CTPA) should be arranged.</li><li>If CTPA cannot be carried out immediately, interim therapeutic anticoagulation should be offered, then hospital admission arranged.</li></ul></li><li>For people with a Wells score of 4 points or less (PE unlikely), a D-dimer test should be arranged with results available within 4 hours.<ul><li>If the test result cannot be obtained within 4 hours, interim therapeutic anticoagulation should be offered while awaiting the result.</li><li>If the test is positive, hospital admission for an immediate CTPA should be arranged. If CTPA cannot be carried out immediately, interim therapeutic anticoagulation should be offered, then hospital admission arranged.</li><li>If the test is negative, interim therapeutic anticoagulation should be stopped and an alternative diagnosis considered.</li></ul></li><li>If PE is confirmed, and anticoagulation treatment is started, in secondary care, follow up of the person in primary care should include:<ul><li>Adequate monitoring of treatment.</li><li>Ensuring that the person is provided with an anticoagulant information booklet, an anticoagulant alert card (which they should be advised to carry at all times), and verbal and written information on anticoagulation treatment.</li><li>Ensuring people with unprovoked PE are offered investigations to assess the possibility of an undiagnosed cancer and, where appropriate, hereditary thrombophilia testing.</li></ul></li></ul><!-- end field 57cc3edf-55dc-4e36-8750-81d5072a7bb5 --><!-- end item 3f213c5e-7075-4e43-9bbd-437eb031e9f1 -->","topic":{"id":"322088c5-226e-5f2b-9fd2-2e2c0678abc1","topicId":"6b233aab-5318-4abb-96fa-1877e917ef2c","topicName":"Pulmonary embolism","slug":"pulmonary-embolism","aliases":[],"chapters":[{"id":"7d60ce89-0a3c-5336-a5d4-755eb5bfb2cd","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"99df9a07-7867-5283-b7c8-4589c8f6e029","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"b4da2d8a-f835-512f-b218-660b7fc61806","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"c60f44ed-a5f4-566e-8718-a289b4d4e969","slug":"changes","fullItemName":"Changes"},{"id":"42a750f4-f134-55a8-a654-9c23ac2a3bfd","slug":"update","fullItemName":"Update"}]},{"id":"b8001d19-4cf2-5db4-b8b5-f082fbff4fbd","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"52656989-9cf4-597c-8118-0fadcb887b21","slug":"goals","fullItemName":"Goals"},{"id":"cdd140ec-bd30-59e9-9777-c921159ea664","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c32413cc-9382-5aaa-b03b-95ed29a1b360","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c1a308a6-aa46-578f-98f1-ed7872474fb4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1629cec2-329a-5273-a313-15a0783d5b22","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d4860e1f-9b8b-5f49-bdb5-fb068af327ab","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9e6802a1-b9c3-5fa9-b632-ef9712c1724b","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"588bb6e5-794e-52df-9953-d91254204285","slug":"definition","fullItemName":"Definition"},{"id":"e2fbb90b-8419-52d9-bfd2-a9eab621be3b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ad38abd5-7668-59b3-828a-9edd427dbdd5","slug":"pathophysiology","fullItemName":"Pathophysiology"},{"id":"9b45f610-d957-50a3-9e85-019832acd145","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8e279dc8-2394-5073-8866-952291c0eee6","slug":"complications","fullItemName":"Complications"},{"id":"8be5980d-145d-5d9c-b255-f057579ce868","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"c07c0850-0c27-58a8-96a8-96051968c076","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"1db70c8e-a80c-587a-8e5e-5adf28878587","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"a71fc8ea-c1d7-5be5-a888-41b834fdca93","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f18a5246-939d-51ce-adb5-f6538871345a","slug":"management","fullItemName":"Management","subChapters":[{"id":"42f102a2-ceab-531f-880e-4075895d9c12","slug":"suspected-pulmonary-embolism","fullItemName":"Scenario: Suspected pulmonary embolism"},{"id":"cd66b55b-908e-56dc-811f-db55be20b710","slug":"confirmed-pulmonary-embolism","fullItemName":"Scenario: Confirmed pulmonary embolism"}]},{"id":"6ae8a494-48a2-5d60-b0f8-39dd5e02489b","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"8b812684-b06c-50e2-86d7-f012b792c674","slug":"parenteral-anticoagulants","fullItemName":"Parenteral anticoagulants"},{"id":"f367e7b5-6b1b-5f42-9d57-a8edab35855f","slug":"oral-anticoagulants","fullItemName":"Oral anticoagulants"}]},{"id":"c1bef62c-2c5a-5588-af53-1a0b4b26d3e3","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"3941fd8f-10fb-53d4-8dc1-3835ad3ca3e3","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"26fc4bf9-2995-5109-9f1e-3ba9ad3dd2dd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f1b2f1f8-81e2-5a3c-b454-2f63f66f6235","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"83fd7f66-6953-54a6-b55f-8d2858a82e97","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd9e363f-a674-594d-8bb9-8779d385e06a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"20c76427-9b00-5da0-bd68-6486385780f2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"96a22dd0-587f-5051-8263-acea49ba216b","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"322088c5-226e-5f2b-9fd2-2e2c0678abc1","topicId":"6b233aab-5318-4abb-96fa-1877e917ef2c","topicName":"Pulmonary embolism","slug":"pulmonary-embolism","aliases":[],"topicSummary":"Pulmonary embolism is a condition in which one or more emboli, usually arising from a blood clot formed in the veins (or, rarely, in the right heart)","lastRevised":"Last revised in October 2020","nextPlannedReviewBy":"2023-01-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2023-01","nextPlannedReviewByDisplay":"January 2023","specialities":[{"id":"ef40c5ff-41df-5fad-804e-7629896151bb","name":"Haematology","slug":"haematology"},{"id":"164e61aa-02a9-5edf-9943-5d891add3a7f","name":"Respiratory","slug":"respiratory"},{"id":"fe645ae3-9536-5dfb-8c84-285b62195550","name":"Cardiovascular","slug":"cardiovascular"}],"chapters":[{"id":"7d60ce89-0a3c-5336-a5d4-755eb5bfb2cd","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"99df9a07-7867-5283-b7c8-4589c8f6e029","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"b4da2d8a-f835-512f-b218-660b7fc61806","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"c60f44ed-a5f4-566e-8718-a289b4d4e969","slug":"changes","fullItemName":"Changes"},{"id":"42a750f4-f134-55a8-a654-9c23ac2a3bfd","slug":"update","fullItemName":"Update"}]},{"id":"b8001d19-4cf2-5db4-b8b5-f082fbff4fbd","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"52656989-9cf4-597c-8118-0fadcb887b21","slug":"goals","fullItemName":"Goals"},{"id":"cdd140ec-bd30-59e9-9777-c921159ea664","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c32413cc-9382-5aaa-b03b-95ed29a1b360","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c1a308a6-aa46-578f-98f1-ed7872474fb4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1629cec2-329a-5273-a313-15a0783d5b22","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d4860e1f-9b8b-5f49-bdb5-fb068af327ab","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9e6802a1-b9c3-5fa9-b632-ef9712c1724b","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"588bb6e5-794e-52df-9953-d91254204285","slug":"definition","fullItemName":"Definition"},{"id":"e2fbb90b-8419-52d9-bfd2-a9eab621be3b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ad38abd5-7668-59b3-828a-9edd427dbdd5","slug":"pathophysiology","fullItemName":"Pathophysiology"},{"id":"9b45f610-d957-50a3-9e85-019832acd145","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8e279dc8-2394-5073-8866-952291c0eee6","slug":"complications","fullItemName":"Complications"},{"id":"8be5980d-145d-5d9c-b255-f057579ce868","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"c07c0850-0c27-58a8-96a8-96051968c076","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"1db70c8e-a80c-587a-8e5e-5adf28878587","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"a71fc8ea-c1d7-5be5-a888-41b834fdca93","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f18a5246-939d-51ce-adb5-f6538871345a","slug":"management","fullItemName":"Management","subChapters":[{"id":"42f102a2-ceab-531f-880e-4075895d9c12","slug":"suspected-pulmonary-embolism","fullItemName":"Scenario: Suspected pulmonary embolism"},{"id":"cd66b55b-908e-56dc-811f-db55be20b710","slug":"confirmed-pulmonary-embolism","fullItemName":"Scenario: Confirmed pulmonary embolism"}]},{"id":"6ae8a494-48a2-5d60-b0f8-39dd5e02489b","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"8b812684-b06c-50e2-86d7-f012b792c674","slug":"parenteral-anticoagulants","fullItemName":"Parenteral anticoagulants"},{"id":"f367e7b5-6b1b-5f42-9d57-a8edab35855f","slug":"oral-anticoagulants","fullItemName":"Oral anticoagulants"}]},{"id":"c1bef62c-2c5a-5588-af53-1a0b4b26d3e3","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"3941fd8f-10fb-53d4-8dc1-3835ad3ca3e3","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"26fc4bf9-2995-5109-9f1e-3ba9ad3dd2dd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f1b2f1f8-81e2-5a3c-b454-2f63f66f6235","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"83fd7f66-6953-54a6-b55f-8d2858a82e97","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd9e363f-a674-594d-8bb9-8779d385e06a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"20c76427-9b00-5da0-bd68-6486385780f2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"96a22dd0-587f-5051-8263-acea49ba216b","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"322088c5-226e-5f2b-9fd2-2e2c0678abc1"}},"staticQueryHashes":["3666801979"]}